Investing in U.S. cannabis? The time is – right – now.

“To those who wait, to the latecomers, you’re going to be left the bones,” Paul Rosen, CEO and Chairman of Tidal Royalty, predicts of those holding back on investment in the burgeoning medical and recreational U.S. cannabis markets.

As one of the first successful investors to take on the Canadian cannabis market, Paul knows a thing or two about striking when opportunity is hot.

With one U.S. state after the next committing to cannabis-related legislative reform, Paul says 2018 and 2019 are the years for building exposure in emerging markets.

Paul believes the market continues to be de-risked but it’s still early in the U.S. so valuations of best-in-class operators are not as inflated as they’ve become in the Canadian cannabis space.

If you want insights on the legal U.S. cannabis industry, financing for cannabis companies and more, sign up for Tidal Royalty’s bi-weekly newsletter.

More uncharted

Q&A with Paul Rosen: Tidal Royalty CEO on valuation metrics and the future of cannabis

Read more

Funding the next stage of growth in the cannabis industry

Read more

Cannabis operators raising money: Get ready for due diligence

Read more

What investors look for in management teams of cannabis companies

Read more

Turning values and vision into an $8 million investment

Read more